Detalhe da pesquisa
1.
Rationale and design of the TUXEDO-2 India study: Ultra-Thin strUt Supraflex Cruz versus XiencE in a Diabetic pOpulation with multi-vessel disease-2.
Am Heart J;
256: 128-138, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36780372
2.
Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes.
N Engl J Med;
373(18): 1709-19, 2015 Oct 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26466202
3.
Impact of catalytic iron on mortality in patients with acute coronary syndrome exposed to iodinated radiocontrast-The Iscom Study.
Am Heart J;
165(5): 744-51, 2013 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23622911
4.
Systemic exposure of sirolimus after coronary stent implantation in patients with de novo coronary lesions: Supralimus-Core® pharmacokinetic study.
Indian Heart J;
64(3): 273-9, 2012.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22664810
5.
Fractional flow reserve [FFR] guided stenting of left main coronary artery in acute coronary syndrome: A single centre experience.
Indian Heart J;
74(1): 69-71, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34902343
6.
Clinical performance of biodegradable polymer-coated sirolimus-eluting stents in unselected real-world population with coronary artery disease: results from the multicenter CORE Registry.
Minerva Cardioangiol;
64(1): 9-14, 2016 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25907696
7.
One-year outcomes of a BioMime™ Sirolimus-Eluting Coronary Stent System with a biodegradable polymer in all-comers coronary artery disease patients: The meriT-3 study.
Indian Heart J;
68(5): 599-603, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27773396